Target volume definition in conformal radiotherapy for prostate cancer: Quality assurance in the MRC RT-01 trial

Radiotherapy and Oncology

Volumn 56, Issue 1, 2000, Pages 73-83

  Seddon, Beatrice ^a   Bidmead, Margaret ^b   Wilson, Jane ^a   Khoo, Vincent ^a   Dearnaley, David ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Conformal radiotherapy; Inter observer variability; Prostate cancer; Quality assurance; Uncertainty

Indexed keywords

ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL PROTOCOL; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER PROGRAM; CONTROLLED STUDY; HUMAN; OBSERVER VARIATION; PRIORITY JOURNAL; PROSTATE CARCINOMA; QUALITY CONTROL; TREATMENT PLANNING;

HUMANS; MALE; MULTICENTER STUDIES; OBSERVER VARIATION; PROSTATIC NEOPLASMS; QUALITY CONTROL; RADIOTHERAPY, CONFORMAL; RANDOMIZED CONTROLLED TRIALS;

EID: 0034237259     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(00)00191-2     Document Type: Article

References (21)

1. Badiozamani K., Wallner K., Cavanagh W., Blasko J. Comparability of CT-based and TRUS-based prostate volumes. Int. J. Radiat. Oncol. Biol. Phys. 43:1999;375-378.
2. Balter J.M., Sandler H.M., Lam K., Bree R.L., Lichter A.S., Ten Haken R.K. Measurement of prostate movement over the course of routine radiotherapy using implanted markers. Int. J. Radiat. Oncol. Biol. Phys. 31:1995;113-118.
3. Bel A., Vos P.H., Rodrigus P.T.R., et al. High-precision prostate cancer irradiation by clinical application of an offline patient set-up verification procedure, using portal imaging. Int. J. Radiat. Oncol. Biol. Phys. 35:1996;321-332.
4. Bijhold J., Lebesque J.V., Hart A.A.M., Vijlbrief R.E. Maximizing set-up accuracy using portal images as applied to a conformal boost technique for prostatic cancer. Radiother. Oncol. 24:1992;261-271.
5. Cazzaniga L., Marinoni M., Bossi A., et al. Interphysician variability in defining the planning target volume in the irradiation of prostate and seminal vesicles. Radiother. Oncol. 47:1998;293-296.
6. Cook L., Cook P., Lee K., et al. An algorithm for volume estimation based on polyhedral approximation. IEEE Trans. Biomed. Eng. 27:1980;493-500.
7. Dearnaley D.P., Shearer R.J., Ellingham L., Gadd J., Horwich A. Rationale and initial results of adjuvant hormone therapy and irradiation for prostate cancer. Motta M., Serio M. Sex hormones and antihormones in endocrine dependent pathology: basic and clinical aspects. 1994;197-208 Elsevier, Amsterdam.
8. Denham J., Dally M., Hunter K., Wheat J., Fahey P., Hamilton C. Objective decision-making following a portal film: the results of a pilot study. Int. J. Radiat. Oncol. Biol. Phys. 26:1993;869-876.
9. Fiorino C., Reni M., Blognesi A., Cattaneo G., Calandrino R. Intra-and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning. Radiother. Oncol. 47:1998;285-292.
10. Huddart R.A., Nahum A., Neal A., et al. Accuracy of pelvic radiotherapy: prospective analysis of 90 patients in a randomized trial of blocked versus standard radiotherapy. Radiother. Oncol. 39:1996;19-29.
11. Kagawa K., Lee W.R., Schultheiss T.E., Hunt M.A., Shaer A.H., Hanks G.E. Initial clinical assessment of CT-MRI image fusion software in localization of the prostate for 3D conformal radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 38:1997;319-325.
12. Ketting C., Austin Seymour M., Kalet I., Hummel S., Jacky J. Consistency of three-dimensional planning target volumes across physicians and institutions. Int. J. Radiat. Oncol. Biol. Phys. 37:1997;445-453.
13. Leunens G., Menten J., Weltens C., Verstraete J., van der Schueren E. Quality assessment of medical decision making in radiation oncology: variability in target volume delineation for brain tumours. Radiother. Oncol. 29:1993;169-175.
14. Mubata C.D., Bidmead A.M., Ellingham L.M., Thompson L.M., Dearnaley D.P. Portal imaging protocol for radical dose-escalated radiotherapy treatment of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 40:1998;221-231.
15. Partin A.W., Yoo J., Carter H.B., et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J. Urol. 150:1993;110-114.
16. Rasch C., Remeijer P., Koper P., et al. Comparison of prostate cancer treatment in two institutions: a quality control study. Int. J. Radiat. Oncol. Biol. Phys. 45:1999;1055-1062.
17. Roach M. III, Faillace-Akazawa P., Malfatti C., Holland J., Hricak H. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 35:1996;1011-1018.
18. TNM classification of malignant tumours. 1992;Springer-Verlag, Geneva.
19. TNM classification of malignant tumours. 1997;Springer-Verlag, Geneva.
20. Urie M., Goitein M., Doppke K., et al. The role of uncertainty analysis in treatment planning. Int. J. Radiat. Oncol. Biol. Phys. 21:1991;91-107.
21. Wilson J., Khoo V.S., Meyer L. Randomised trial of high dose conformal radiotherapy for prostate cancer: initial report of acute toxity. Br. J. Cancer. 78:(Suppl 2):1998;P021.